ALB vs VXRT · $8.00B cap vs rev $28.7M
Albemarle Corp (ALB) versus Vaxart Inc (VXRT) — a side-by-side from cached financials, not a winner call.
Albemarle Corp (ALB) is a specialty chemicals company listed on US.
Vaxart Inc (VXRT) is a biotechnology company listed on US.
ALB does not have a complete income-statement cache yet.
Latest reported VXRT revenue for 2024-12-31 was $28.7M. Net income was -$66.9M. Revenue was up 288.9% from 2023-12-31 to 2024-12-31. VXRT currently screens at market cap $73.0M.
ALB currently screens at market cap $8.00B. VXRT currently screens at market cap $73.0M.
Not investment advice. Open the ALB and VXRT stock pages for the full models.
Not investment advice.